AP PHarma as announced that it has received a Complete Response Letter (CRL) from the FDA regarding its New Drug...
The FDA has approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults...
Boston Scientific Corporation announced it exercised its option to acquire the remaining shares of Millipede, Inc, a privately-held company in...
Omeros Corporation announced that the results of four real-world clinical studies evaluating the benefits of Omidria (phenylephrine and ketorolac intraocular...
The purpose of this study is to evaluate the efficacy and safety of IV antifrolumab in adult patients with Active Proliferative Lupus Nephritis
Reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension in adults (including the elderly). Reduction of elevated IOP in paediatric patients with elevated IOP and paediatric glaucoma.
Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma.
Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.